Additionally, ATAD2 is proven to be a marker and driver of cell proliferation in ovarian cancer, and MYBL2-ATAD2 proliferative signalling axis is confirmed by Liu et al.7 This evidence concerns the gene ATAD2 and ovarian carcinoma.